Stocks were indicated to open up marginally higher on Tuesday, but the S&P 500 is again back up within 10 points of that all-time high that was seen in February, before the COVID-19 pandemic sent the economy into an instant recession. Amazingly, the S&P is up over 50% from the March panic-selling lows. Earnings season has been winding down, and many investors feel as though they may have missed out on the recovery rally. This has investors looking for new ideas for how to be positioned in the second half of 2020 and ahead of the election.
24/7 Wall St. reviews dozens of analyst research reports each day of the week in an effort to find new ideas for long-term investors and short-term traders alike. Some analyst reports cover stocks to buy, and others cover stocks to sell or avoid.
Now that stocks have recovered so much, daily analyst calls have basically normalized, with fewer extreme target changes. Remember that no single analyst call should ever be used as a basis to buy or sell a stock. Consensus analyst target data is from Refinitiv.
These are the top analyst upgrades, downgrades and initiations from Tuesday, August 18, 2020.
AMAG Pharmaceuticals Inc. (NASDAQ: AMAG) was downgraded to Equal Weight from Overweight at Barclays. Shares closed up 3% at $10.89 on Monday and were indicated up 5% at $11.45 on Tuesday.
Anheuser-Busch InBev S.A./N.V. (NYSE: BUD) was reiterated as Buy and its price target was raised to $62 from $52 (versus a $56.19 prior close) at Argus.
Annexon Inc. (NASDAQ: ANNX) was started with a Buy rating and a $33 price objective (versus a $26.55 close) at BofA Securities.
At Home Group Inc. (NYSE: HOME) was reiterated as Buy and its price objective was raised to $54 from $45 at BofA Securities.
Best Buy Co. Inc. (NYSE: BBY) was reiterated as Outperform and its target price was raised to $130 from $95 at Wedbush Securities.
CarMax Inc. (NYSE: KMX) was reiterated as Outperform and its target price was raised to $120 from $100 (versus a $105.62 close) at Wedbush.
Coherent Inc. (NASDAQ: COHR) was named as the Zacks Bear of the Day stock. The firm said that slowdown in laser tooling needs for mobile and automotive markets this year hit sales by 15% and profits by 55%. Shares last closed at $122.35 and have a consensus price target of $161.89.
Elanco Animal Health Inc. (NYSE: ELAN) was reiterated as Buy and its target price was raised to $30 from $26 (versus a $25.85 close) at Argus.
General Motors Co. (NYSE: GM) was reiterated as Overweight and its price target was raised to $46 from $43 (versus a $30.01 close) at Morgan Stanley. GM had a $39 consensus target price.
Home Depot Inc. (NYSE: HD) was given a quick glance after reporting earnings, and Wedbush maintained its Neutral rating and $270 price target. Home Depot closed up 2.7% at $288.24 ahead of earnings and was last seen up 0.5% at $290.00.
Howmet Aerospace Inc. (NYSE: HWM) was downgraded to Hold from Buy at Argus.
Inozyme Pharma (NASDAQ: INZY) was started as Outperform with a $35 price target (versus a $29.00 close) at Wedbush. Piper Sandler started it with an Overweight rating and a $40 price target.
Intercontinental Exchange Inc. (NYSE: ICE) was downgraded to Perform from Outperform at Oppenheimer.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.